在血液学疾病中T细胞枯竭的偶发性干细胞移植的有效性和可靠性:一项回顾性研究
Burak Deveci1, George Kublashvili2, Ayse Tuba Oztekin2
1Antalya Bilim University, Vocational School of Health Services, Antalya, Türkiye.
Transplantation proceedings
|January 11, 2024
概括
耗尽T细胞的平分异性干细胞移植显示出减少并发症和改善血液恶性瘤患者的存活率的前景. 这种方法虽然有效,但需要仔细考虑患者的因素和潜在的死亡风险因素.
科学领域:
- 血液学 血液学 血液学
- 移植免疫学 移植免疫学
- 在瘤学瘤学.
背景情况:
- 顺序相同的干细胞移植 (HSCT) 正在推进T淋巴细胞枯竭策略.
- 这种方法旨在减少非复发性死亡率和移植对宿主疾病.
- 然而,它涉及更高的成本和专门的设施要求.
研究的目的:
- 评估接受HSCT的患者的复发率,生存结果和临床数据.
- 分析在平分异性移植中阿尔法-β (αβ) T 细胞枯竭的有效性和结果.
主要方法:
- 一项涉及56名成年患者的回顾性研究.
- 患者接受了利用αβT细胞枯竭的哈普洛同一性干细胞移植.
主要成果:
- 患者的中位数年龄为41.5岁;女性为39.3%.
- 移植后复发发生在17.9%的患者中;整体死亡率为55.4%.
- 增加死亡率的危险因素包括年龄较大 (>40岁),高血压,急性肝移植对宿主疾病和全身真菌感染.
结论:
- 耗尽T细胞的HSCT是一种有效和可靠的方法,用于平分异性移植.
- 这种技术可能会降低发病率并提高无复发的生存率.
- 对于患有血性恶性瘤的年轻患者来说,它尤其有益,因为这些患者需要单独的捐赠者移植.
相关概念视频
Bone Marrow Sampling and Transplants
332
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
332
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Tissue Transplantation
372
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
372


